We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Magnisense Receives €1.2M for Development of CVD Tests

News   Feb 03, 2015

 
Magnisense Receives €1.2M for Development of CVD Tests
 
 
 

RELATED ARTICLES

Triple-negative Breast Cancer Influenced by Dual Action of Genes and RNA

News

Women with triple-negative breast cancer could be differentiated from a more common form of the disease by a panel of 17 small RNA molecules.

READ MORE

International Alliance Aims To Detect the (Almost) Undetectable

News

A new transatlantic research alliance aims to develop radical new strategies and technologies to detect cancer at its earliest stage.

READ MORE

Changes Associated With Alzheimer's Disease Detectable in Blood Samples

News

Researchers have discovered new changes in blood samples which are associated with Alzheimer’s disease.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE